NCT00206323View on ClinicalTrials.gov

A Randomized, Placebo-controlled, Tourette Syndrome Study.

PHASE3CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
Tourette Syndrome
Interventions
DRUG

Topiramate (drug)

Topiramate 25 mg titrated to 200 mg

DRUG

placebo/sugar pill

placebo

All Listed Sponsors
collaborator

Ortho-McNeil Janssen Scientific Affairs, LLC

INDUSTRY

lead

Baylor College of Medicine

OTHER

NCT00206323 - A Randomized, Placebo-controlled, Tourette Syndrome Study. | Biotech Hunter | Biotech Hunter